Dizziness; chills; fever; muscle aches; joint pain; migraine; diarrhea; nausea; brain fog; redness at injection site; swelling of arm at injection site; racing heart; face cheeks felt like they were severely sunburned; red rash spreading across the injection site and beyond; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Oct2021 (Lot number: EW0158) at the age of 69 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hashimoto''s Disease" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; METO [METOPROLOL TARTRATE]. Vaccination history included: Bnt162b2 (Dose 2, Single, Batch/Lot No: EL9261, Location of injection: Arm Left, Vaccine Administration Time: 02:45 PM), administration date: 12Feb2021, when the patient was 68 years old, for COVID-19 Immunization; Bnt162b2 (Dose 1, Single, Batch/Lot No: EL1283, Location of injection: Arm Left, Vaccine Administration Time: 02:45 PM), administration date: 22Jan2021, when the patient was 68 years old, for COVID-19 Immunization. The following information was reported: DIZZINESS (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "Dizziness"; CHILLS (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "chills"; PYREXIA (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "fever"; MYALGIA (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "muscle aches"; ARTHRALGIA (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "joint pain"; MIGRAINE (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "migraine"; DIARRHOEA (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "diarrhea"; NAUSEA (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "nausea"; FEELING ABNORMAL (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "brain fog"; VACCINATION SITE ERYTHEMA (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "redness at injection site"; VACCINATION SITE SWELLING (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "swelling of arm at injection site"; PALPITATIONS (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "racing heart"; BURNING SENSATION (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "face cheeks felt like they were severely sunburned"; VACCINATION SITE RASH (non-serious) with onset 08Oct2021 22:30, outcome "recovering", described as "red rash spreading across the injection site and beyond". Therapeutic measures were not taken as a result of dizziness, chills, pyrexia, myalgia, arthralgia, migraine, diarrhoea, nausea, feeling abnormal, vaccination site erythema, vaccination site swelling, palpitations, burning sensation, vaccination site rash.  Additional information: Facility type vaccine was reported as clinic. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID since the vaccination.  No follow-up attempts are possible. No further information is expected.